0102030405
GRAZOPREVIR Intermediates CAS No 1425038-20-5 Pharmaceutical Intermediates
02
introduce
Methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)-2-(methoxycarbonyl)pyrrolidine mesylate is a special compound with a complex molecular structure that is mainly used in the pharmaceutical industry. The compound is characterized by its unique atomic arrangement, which contributes to its potential therapeutic applications. The presence of chloroquinoxaline and methoxycarbonyl groups enhances its reactivity and biological activity, making it a promising candidate for drug development.
02
Physical and chemical properties
- Molecular formula: C16H20ClN3O7S
- Molecular weight: 433.86 g/mol
- Appearance:White to Off-White solid.
- Solubility: It is soluble in polar organic solvents such as methanol and dimethyl sulfoxide (DMSO), making it easy to incorporate into various formulations.
- Melting Point: The melting point of this compound is about 150-155°C, indicating good thermal stability.
- Stability: The compound exhibits excellent stability under standard laboratory conditions, ensuring reliable performance in pharmaceutical applications.
The addition of methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)-2-(methoxycarbonyl)pyrrolidine methanesulfonate to a pharmaceutical formulation has several advantages:
1. Potential Therapeutic Applications: The unique structure of this compound can be explored in various therapeutic areas, including oncology, neurology, and infectious diseases, making it a promising candidate for drug development.
2. Enhanced biological activity: The combination of pyrrolidine and chloroquinoxaline moieties can enhance the biological activity of the compound, thereby improving the efficacy of therapeutic applications.
3. Compatibility with other compounds: This compound can be easily incorporated into multi-drug formulations, enhancing the overall effectiveness of the treatment regimen.
4. Diverse formulation options: The solubility characteristics of the compound allow for a variety of formulation strategies, including oral, injection, and topical application, to meet the needs of different patients.
In the field of drug development, methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)-2-(methoxycarbonyl)pyrrolidine mesylate is a key intermediate in the synthesis of various pharmaceutical compounds. Its unique properties allow researchers to explore new therapeutic avenues, especially in the field of drug discovery and development. The compound is capable of further chemical modifications, making it an attractive candidate for the development of innovative drugs to address unmet medical needs.
As a factory integrating production and trading, we are proud of our commitment to quality and customer satisfaction. Our state-of-the-art production facilities and strict quality control processes ensure that each batch of Methyl (2S, 4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)-2-(methoxycarbonyl)pyrrolidine methanesulfonate meets the highest industry standards. We understand the importance of a reliable supply chain in the pharmaceutical industry and we are committed to providing our customers with a continuous supply of high-quality raw materials.
In summary, methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)-2-(methoxycarbonyl)pyrrolidine mesylate is an important compound for the pharmaceutical industry, offering numerous advantages for drug development and formulation. With our expertise and commitment to quality, we are a trusted partner for all your chemical needs. Contact us today to learn more about how our products can support your research and development efforts.